Eckert & Ziegler BEBIG, Mick Radio-Nuclear Instruments, WOLF-Medizintechnik (WOmed)

Press Releases

We are keeping you informed! If you have questions regarding our press releases, feel free to contact us via the website´s contact form. Stay up-to-date with our companies latest news:

SagiNova® afterloader launch in Japan at the 29th JASTRO Annual Meeting

Seneffe, Belgium, November 24, 2016, Eckert & Ziegler BEBIG announces the launch of its HDR brachytherapy afterloader, SagiNova®, and the corresponding treatment planning software, SagiPlan®, during the 29th Japanese Society for Radiation Oncology (JASTRO) Annual Meeting in Kyoto.

The system will be presented at the booth of Eckert & Ziegler BEBIG's Japanese distributor, Euro Meditech Co., Ltd. After receiving clearance from the Pharmaceuticals and Medical Devices Agency in Japan (PMDA), the 29th JASTRO will be the first to showcase SagiNova® in the country.

SagiNova® is the successor of the MultiSource® afterloader. In total, Eckert & Ziegler BEBIG has installed over 40 afterloaders in Japan. With this figure, the country is one of the largest markets for Eckert & Ziegler BEBIG HDR brachytherapy products. "We are very excited to start marketing our new system and we expect the advances of SagiNova® and SagiPlan® to be well received by the JASTRO audience", says Kelvin Ng, Area General Manager, Asia-Pacific.

SagiNova® integrates the exceptional features of the MultiSource® afterloader, including the choice between a cobalt-60 and iridium-192 source, the integrated In-Vivo Dosimetry System, automatic length measurement and digital source position verification. A new hardware and software platform allows for new features, two of them being the 50-channel support and the highly customizable tool QAssist, offering pre-defined quality assurance tests to verify that the system and critical components are operating correctly. The newly added remote control allows for short response times.

Like SagiNova®, SagiPlan® includes a new graphical user interface. Moreover, it is distinguished by its enhanced DICOM and plan features, as well as its improved prostate module.

About High Dose Rate (HDR) Brachytherapy
HDR brachytherapy allows radiation oncologists to deliver the radiation quickly, most often as an outpatient procedure. During this procedure a computer driven apparatus, called a remote afterloading device, pushes the radioactive source attached to a drive wire through transfer tubes and applicators to the treatment site. The radioactive source can be moved in millimeter increments and remain in a certain position (dwell position) for a predetermined amount of time to optimize the dose delivered. When the desired treatment dose has been achieved, the remote afterloading device automatically withdraws the radioactive source so there is no residual radiation or radioactivity.
HDR brachytherapy has been used since the 1960s and today is applied to treat cancers in body sites such as gynecological, rectal, prostate and breast. The procedure enables an accurate and precise tumor-specific radiation dose delivery in a shorter course of treatment compared to other types of radiation treatment modalities while preserving the structure and function of the organ(s) treated and nearby.

About Eckert & Ziegler BEBIG
Contributing to saving lives!
Eckert & Ziegler BEBIG is a European-based group active in the medical device segment of the health care industry. Its core business is the production and distribution of medical products for the treat­ment of cancer using brachytherapy. The company's headquarters are in Belgium, with production facilities in Germany and in the USA, as well as subsidiaries throughout Europe, the USA, India and Brazil. In addition, Eckert & Ziegler BEBIG has a worldwide network of distributors and agents to support the international marketing and distribution of its product line. The company's products and equipment are intended for use by oncologists, radiotherapists, urologists, ophthalmologists and medical physicists.
Eckert & Ziegler BEBIG employs approximately 130 people. The company has been listed on the Euronext stock exchange since April 1997.

Annica Witt
Marketing Communication Manager